Roche Holding AG

FDA approves Roche Ebola test for emergency use

Roche Holding AG said U.S. health regulators have approved its Ebola test for emergency use in response to the world's worst outbreak of the disease in West Africa

Read Full Article

Bristol-Myers sues Merck over U.S. immunotherapy patent

Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.

Read Full Article

U.S. approval of Merck cancer immunotherapy expected soon

U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.

Read Full Article

Roche to buy U.S. biotech firm InterMune for $8.3 billion

Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

Read Full Article

Roche CEO denies credit financing for acquisition

Roche Holding AG's CEO Severin Schwan said the company won't raise any credit financing after a report from the DealReporter said Roche would acquire BioMarin Pharmaceuticals.

Read Full Article

Alexion to enlist Goldman Sachs after Roche’s takeover offer

Alexion Pharmaceuticals hired Goldman Sachs to negotiate prices for a potential takeover deal from Roche Holding AG.

Read Full Article

Roche seeks financing for potential bid

Roche Holding AG is currently seeking financing for a potential bid for Alexion Pharmaceuticals.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics